1. Kim JH. Combined use of tomoxifen, cyclosporin-A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines. Yosei Med J 1993; 34: 35–44.
2. Pasman PC. Multidrug resistance mediated by P-glycoprotein in haematological malignancies. Neth J Med 1993; 4: 218–231.
3. Fields KK. Two novel high-dose treatment regimens for metastatic breast cancer-ifosfamide, carboplatin, plus etoposide, and mitoxantrane plus thiotepa. Outcomes and toxicities. Semin Oncol 1993; 20: 59–66.
4. Toffoli G. Doxorubicin, vincristine, actinomycin-D, but not teniposide require long-lasting uninterrupted verapamil pressure to overcome drug resistance in multidrug resistant cells. Cancer Detect Prev 1993; 17: 425–43.
5. Ibrahim A. High-dose chemotherapy with etopiside, cyclophosphamide, and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study. Eur J Cancer 1993; 29A: 1398–1403.